Keyword Tag Sort by

MDV3100 News (3 articles)

New Targeted Therapy Effective in Treating Advanced Prostate Cancer

NEW YORK, NY - An experimental drug is showing promise for the treatment of men with an aggressive form of advanced prostate cancer. A new multicenter study has concluded that the targeted therapy MDV3100 is safe and effective for patients with castration-resistant prostate cancer (CRPC), known...

Published on 15 April 2010, 05:51

New Drug for Advanced Prostate Cancer Shows Promise

OHSU Knight Cancer Institute is one of four centers worldwide to evaluate the new compoundA new drug called MDV3100 has shown significant promise in lowering the prostate specific antigen (PSA) levels ‑ a marker for tumor growth ‑ in men with advanced prostate cancer who have no other option...

Published on 16 April 2009, 10:50

New drug shows promise in treating drug-resistant prostate cancer

A new therapy for metastatic prostate cancer has shown considerable promise in early clinical trials involving patients whose disease has become resistant to current drugs. Chemists and biologists at UCLA and colleagues at several other institutions, including Memorial Sloan-Kettering Cancer...

Published on 9 April 2009, 19:51